Search

Your search keyword '"Ortega, Gemma"' showing total 49 results

Search Constraints

Start Over You searched for: Author "Ortega, Gemma" Remove constraint Author: "Ortega, Gemma" Search Limiters Full Text Remove constraint Search Limiters: Full Text
49 results on '"Ortega, Gemma"'

Search Results

1. Cyclosporine A in hospitalized COVID-19 pneumonia patients to prevent the development of interstitial lung disease: a pilot randomized clinical trial

2. Unveiling the sound of the cognitive status: Machine Learning-based speech analysis in the Alzheimer’s disease spectrum

3. Author Correction: Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores

4. A randomized, open-label clinical trial in mild cognitive impairment with EGb 761 examining blood markers of inflammation and oxidative stress

5. Differences in macular vessel density in the superficial plexus across cognitive impairment: the NORFACE cohort

6. Automatized FACEmemory® scoring is related to Alzheimer’s disease phenotype and biomarkers in early-onset mild cognitive impairment: the BIOFACE cohort

7. Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores

8. Author Correction: Interaction of neuropsychiatric symptoms with APOE ε4 and conversion to dementia in MCI patients in a Memory Clinic

9. Neuropsychiatric profiles and conversion to dementia in mild cognitive impairment, a latent class analysis

10. Interaction of neuropsychiatric symptoms with APOE ε4 and conversion to dementia in MCI patients in a Memory Clinic

11. A computerized version of the Short Form of the Face-Name Associative Memory Exam (FACEmemory®) for the early detection of Alzheimer’s disease

12. Evaluation of macular thickness and volume tested by optical coherence tomography as biomarkers for Alzheimer’s disease in a memory clinic

13. Author Correction: Usefulness of peripapillary nerve fiber layer thickness assessed by optical coherence tomography as a biomarker for Alzheimer’s disease

14. Macular vessel density in the superficial plexus is not associated to cerebrospinal fluid core biomarkers for Alzheimer’s disease in individuals with mild cognitive impairment: The NORFACE cohort

15. Visual impairment in aging and cognitive decline: experience in a Memory Clinic

16. The Synergic Effect of AT(N) Profiles and Depression on the Risk of Conversion to Dementia in Patients with Mild Cognitive Impairment

17. Usefulness of peripapillary nerve fiber layer thickness assessed by optical coherence tomography as a biomarker for Alzheimer’s disease

18. Abstract WP21: Cognitive Improvement In Patients With Dural Arterio-venous Fistula After Endovascular Embolization: Interim Analysis Of The NAIF Study

19. Aplicacions especials dels materials compostos amb fibres vegetals

20. New insights into the genetic etiology of Alzheimer's disease and related dementias

21. Aplicacions especials dels materials compostos amb fibres vegetals

22. Neuropsychiatric Profile as a Predictor of Cognitive Decline in Mild Cognitive Impairment

23. Functional respiratory impairment and related factors in patients with interstitial pneumonia with autoimmune features (IPAF): Multicenter study from NEREA registry.

24. Biomarker-Based Risk Prediction of Alzheimer's Disease Dementia in Mild Cognitive Impairment: Psychosocial, Ethical, and Legal Aspects Study Protocol of the PreDADQoL Project

25. Common variants in Alzheimer's disease and risk stratification by polygenic risk scores

26. Biomarker-Based Risk Prediction of Alzheimer’s Disease Dementia in Mild Cognitive Impairment: Psychosocial, Ethical, and Legal Aspects

28. Amyloid deposition in adults with drug‐resistant temporal lobe epilepsy.

29. Psicopompós o El juego de las alegorías

30. Exploring Genetic Associations of Alzheimer's Disease Loci With Mild Cognitive Impairment Neurocognitive Endophenotypes

31. Subtle executive deficits are associated with higher brain amyloid burden and lower cortical volume in subjective cognitive decline: the FACEHBI cohort.

32. Exploring Genetic Associations of Alzheimer’s Disease Loci With Mild Cognitive Impairment Neurocognitive Endophenotypes

33. MAPT H1 haplotype is associated with late-onset Alzheimer's disease risk in APOE ε 4 noncarriers: Results from the dementia genetics Spanish consortium

36. Additional file 3 of Association between retinal thickness and β-amyloid brain accumulation in individuals with subjective cognitive decline: Fundació ACE Healthy Brain Initiative

37. Additional file 1 of Association between retinal thickness and β-amyloid brain accumulation in individuals with subjective cognitive decline: Fundació ACE Healthy Brain Initiative

38. Additional file 1 of Association between retinal thickness and β-amyloid brain accumulation in individuals with subjective cognitive decline: Fundació ACE Healthy Brain Initiative

39. New insights on the genetic etiology of Alzheimer’s and related dementia

40. Additional file 2 of Association between retinal thickness and β-amyloid brain accumulation in individuals with subjective cognitive decline: Fundació ACE Healthy Brain Initiative

41. Additional file 2 of Association between retinal thickness and β-amyloid brain accumulation in individuals with subjective cognitive decline: Fundació ACE Healthy Brain Initiative

42. Breve historia del mito

43. Breve historia del mito

44. Breve historia del mito

45. Breve historia del mito

46. Psychological outcomes of dementia risk estimation in MCI patients: Results from the PreDADQoL project.

47. Association between retinal thickness and β-amyloid brain accumulation in individuals with subjective cognitive decline: Fundació ACE Healthy Brain Initiative.

48. Genome-wide significant risk factors on chromosome 19 and the APOE locus.

49. The Spanish version of Face-Name Associative Memory Exam (S-FNAME) performance is related to amyloid burden in Subjective Cognitive Decline.

Catalog

Books, media, physical & digital resources